Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 5.08 is 50% above its 2-year average of 3.38, around the middle of its 2-year range (0.00–8.60).
As of the fiscal period ended Tuesday, June 30, 2026. 9.41% below its 12-month average of 5.61.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.08.
QUICK RATIO (ACID-TEST)
5.08
QUICK RATIO (ACID-TEST) AVG TTM
5.61
QUICK RATIO (ACID-TEST) AVG 3Y
N/A
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-9.41%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 561 covered companies
CURRENT VS SECTOR MEDIAN
+69.90%
vs the sector median at left
Heartflow, Inc. Common Stock
Market Cap
$4.43B
Quick Ratio (Acid-Test)
5.08
TTM Avg
5.61
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.44B
Quick Ratio (Acid-Test)
0.66
TTM Avg
0.63
3Y Avg
0.81
5Y Avg
1.13
Market Cap
$4.66B
Quick Ratio (Acid-Test)
4.68
TTM Avg
3.02
3Y Avg
3.88
5Y Avg
4.28
Market Cap
$4.33B
Quick Ratio (Acid-Test)
16.24
TTM Avg
19.89
3Y Avg
20.20
5Y Avg
22.94
Market Cap
$4.69B
Quick Ratio (Acid-Test)
1.38
TTM Avg
1.51
3Y Avg
1.37
5Y Avg
1.40
Market Cap
$4.73B
Quick Ratio (Acid-Test)
6.95
TTM Avg
6.77
3Y Avg
6.23
5Y Avg
10.87
Market Cap
$4.21B
Quick Ratio (Acid-Test)
12.63
TTM Avg
10.52
3Y Avg
9.25
5Y Avg
8.76
Market Cap
$4.80B
Quick Ratio (Acid-Test)
26.10
TTM Avg
14.27
3Y Avg
14.23
5Y Avg
14.47
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Heartflow, Inc. Common Stock (HTFL) | $4.43B | 5.08 | 5.61 | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.44B | 0.66 | 0.63 | 0.81 | 1.13 |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.66B | 4.68 | 3.02 | 3.88 | 4.28 |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.33B | 16.24 | 19.89 | 20.20 | 22.94 |
| LifeStance Health Group, Inc. (LFST)vs › | $4.69B | 1.38 | 1.51 | 1.37 | 1.40 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.73B | 6.95 | 6.77 | 6.23 | 10.87 |
| AbCellera Biologics Inc. (ABCL)vs › | $4.21B | 12.63 | 10.52 | 9.25 | 8.76 |
| LivaNova PLC (LIVN)vs › | $4.17B | 1.21 | 1.83 | 2.18 | 1.91 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.80B | 26.10 | 14.27 | 14.23 | 14.47 |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.86B | 2.74 | 2.74 | 3.13 | 4.87 |
Quick Ratio
5.08
Excludes inventory
Current Ratio
5.08
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 5.08 |
| 2026-03-31 | 5.57 |
| 2025-12-31 | 5.20 |
| 2025-09-30 | 8.60 |
| 2025-06-30 | 3.60 |
| 2025-03-31 | 3.33 |
| 2024-12-31 | 2.45 |
| 2024-09-30 | 0.00 |
| 2024-06-30 | 0.00 |
| 2024-03-31 | 0.00 |
